High-Purity Levodopa (L-DOPA) 99% CAS 59-92-7: Pharmaceutical Chemical Intermediate
Discover the vital role of Levodopa (L-DOPA) as a key pharmaceutical intermediate, essential for neurotransmitter synthesis and therapeutic applications.
Get a Quote & SampleProduct Core Value
Levodopa
Levodopa, chemically known as L-3,4-dihydroxyphenylalanine (L-DOPA), is a critical amino acid functioning as a direct precursor to neurotransmitters such as dopamine, norepinephrine, and epinephrine. Its high purity of 99% and specific CAS number 59-92-7 make it indispensable in the pharmaceutical industry.
- As a vital neurotransmitter precursor, Levodopa is central to pharmaceutical synthesis.
- Levodopa is the primary pharmaceutical chemical used in treating Parkinson's disease.
- The high purity of 99% ensures efficacy and safety in medical applications.
- Levodopa, a key pharmaceutical intermediate, supports the synthesis of vital brain chemicals.
Key Benefits Provided by Levodopa
Neurotransmitter Synthesis Support
Levodopa plays a crucial role as a precursor in the biosynthesis of essential neurotransmitters like dopamine, which are vital for brain function and movement regulation.
Parkinson's Disease Treatment
Leveraging its dopamine-boosting properties, Levodopa is the cornerstone medication for managing the symptoms of Parkinson's disease, significantly improving patient quality of life.
High Chemical Purity
With a purity degree of 99%, this Levodopa chemical intermediate ensures reliable and effective outcomes in pharmaceutical applications and research.
Key Applications
Pharmaceutical Synthesis
Levodopa is a cornerstone in the synthesis of various pharmaceutical compounds, particularly those targeting neurological disorders.
Neurotransmitter Precursor
As a direct precursor to dopamine, Levodopa is fundamental for maintaining adequate levels of this critical neurotransmitter in the brain.
Parkinson's Disease Therapy
The primary medical application of Levodopa is in the treatment of Parkinson's disease, alleviating motor symptoms and improving patient mobility.
Dopamine-Responsive Dystonia Management
Levodopa also serves as a crucial therapeutic agent for managing symptoms associated with dopamine-responsive dystonia.